Dr. Mary Mihalyo

With more than 20 years’ experience in hospice clinical pharmacy services and as the CEO of Delta Care Rx, Dr. Mary Mihalyo has revolutionized the provision of quality, effective, competitively priced pharmacotherapy solutions to hospice and palliative care patients.

She also has helped educate and train a generation of pharmacists, having served since 1998 as an Assistant Professor of Pharmacy Practice at her alma mater, the Duquesne University School of Pharmacy. As an assistant professor of pharmacy, she participates in both didactic and experiential teaching with a focus on pain management and hospice and palliative care.

A pioneer in medication therapy management services for hospice providers, Dr. Mihalyo helped to found Delta Care Rx in 2012 to work exclusively with hospice and palliative care providers. She has built a corporate culture at Delta Care Rx focused on transparency, excellence, patient-centered quality care, education and support for hospice clinicians, and unyielding customer service. Her motivation in forming Delta Care was to create an advocate for pharmacist support for hospice clinicians at the bedside while ensuring sustainable relationships between local hospice providers and community-based pharmacies.

Dr. Mihalyo received her Bachelor of Science and Doctor of Pharmacy degrees from the Duquesne University School of Pharmacy. She is a Board Certified Pharmacotherapy Specialist and she completed the Palliative Care Education and Practice (PCEP) course provided by the Harvard Medical School Center for Palliative Care.

She is a frequent speaker to national, regional and state hospice and palliative care conferences, often advocating for the vital role of clinical pharmacists working collaboratively with hospice and palliative care clinicians to ensure quality, effective pharmacotherapy interventions at the bedside. Dr. Mihalyo also publishes frequently in clinical and academic journals in collaboration with esteemed peers.